What is he best known for?
The fields of study he is best known for:
His primary areas of study are Vascular smooth muscle, Cell biology, Heme oxygenase, Internal medicine and Endocrinology.
His Vascular smooth muscle research includes themes of Messenger RNA, In vivo and Biochemistry.
His work in In vivo is not limited to one particular discipline; it also encompasses Molecular biology.
His work deals with themes such as Cell, Protein kinase B, Beta-catenin, Wnt signaling pathway and Aorta, which intersect with Cell biology.
His Internal medicine research focuses on Endothelium in particular.
His Endothelium study combines topics from a wide range of disciplines, such as Cell cycle and Pharmacology.
His most cited work include:
- Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis (735 citations)
- Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. (471 citations)
- Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. (361 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Molecular biology, Antibody, Vascular smooth muscle, Cell biology and Biochemistry.
His Molecular biology research incorporates elements of Enhancer, Transcription, Gene, Transfection and Antigen.
His research on Antibody also deals with topics like
- Multiple sclerosis, which have a strong connection to A protein,
- Cancer research together with Cancer and Tumor necrosis factor alpha.
Chung-Ming Hsieh is investigating Vascular smooth muscle as part of his inquiry into Endocrinology and Internal medicine.
His Cell biology study also includes
- Smooth muscle which intersects with area such as Molecular cloning,
- Cell which connect with Aorta.
He combines subjects such as Epitope and Antigen binding with his study of Biochemistry.
He most often published in these fields:
- Molecular biology (38.54%)
- Antibody (20.83%)
- Vascular smooth muscle (20.83%)
What were the highlights of his more recent work (between 2012-2018)?
- Antibody (20.83%)
- Biochemistry (18.75%)
- Molecular biology (38.54%)
In recent papers he was focusing on the following fields of study:
Chung-Ming Hsieh mainly focuses on Antibody, Biochemistry, Molecular biology, Nucleic acid and Multivalent binding.
His Antibody course of study focuses on Receptor and Multiple sclerosis, Monoclonal antibody, A protein and Cell biology.
His Biochemistry research incorporates themes from Antigen binding and Primary and secondary antibodies.
His Molecular biology research is mostly focused on the topic Liaison.
Chung-Ming Hsieh has researched Nucleic acid in several fields, including Virus and SV40 T-antigen.
His Multivalent binding study combines topics in areas such as Combinatorial chemistry, Cell Surface Display Technology and Yeast display.
Between 2012 and 2018, his most popular works were:
- Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β. (42 citations)
- Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate. (17 citations)
- Multivalent binding protein compositions (12 citations)
In his most recent research, the most cited papers focused on:
Chung-Ming Hsieh mostly deals with Molecular biology, Biochemistry, Antigen, Antibody and Multivalent binding.
His studies deal with areas such as Pharmacokinetics and Pathogenesis as well as Molecular biology.
The various areas that he examines in his Biochemistry study include Antigen binding, Flow cytometry and Primary and secondary antibodies.
His studies in Antibody integrate themes in fields like Potency, Chemokine, Receptor, Matrix metalloproteinase and Cell biology.
His Multivalent binding study frequently intersects with other fields, such as Nucleic acid.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
